Examination of Cognitive Function in Patients Treated With Subutex
- Conditions
- Opiate Addiction
- Interventions
- Other: Sexual, cognitive functional tests and measurement weight
- Registration Number
- NCT00687089
- Lead Sponsor
- BeerYaakov Mental Health Center
- Brief Summary
People who addicted to Heroin and other opiates suffer from a disease with approved genetic basis. It causes to a behavioral response as searching and using those drugs even though they know it causes severe damages as physiological, familiar and legal affairs.
The popular treatment's goal is to "clean" the people from any drug. In a medical and pharmacological point of view there is no sense in this approach for all people. This point of view believes that Buprenorphine (Subutex) is a correct pharmacological treatment.
The hypothesis of this research is that people using Buprenorphine have difficulties in gaining weight, in sexual and cognitive function (according to subjects' reports)
- Detailed Description
People who addicted to Heroin and other opiates suffer from a disease with approved genetic basis. It causes to a behavioral response as searching and using those drugs even though they know it causes severe damages as physiological, familiar and legal affairs.
The popular treatment's goal is to "clean" the people from any drug. In a medical and pharmacological point of view there is no sense in this approach for all people. This point of view believes that Buprenorphine (Subutex) is a correct pharmacological treatment.
The hypothesis of this research is that people using Buprenorphine have difficulties in gaining weight, in sexual and cognitive function (according to subjects' reports) We examine people who stopped opiates and began Buprenorphine. Every participant in the study will have two visits: the first one before receiving Buprenorphine and the second one after 3 months of receiving Buprenorphine.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- People who suffer from addiction problems (opiates)
- People who willing to to start Buprenorphine treatment
- People who willing to cooperate with study tests and questionnaires
- People aged 18 to 70
- People who suffer from any neurocognitive problems
- People who suffer from mental illnesses
- People who are having legal guardian
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Subutex group Sexual, cognitive functional tests and measurement weight People who used opiates and willing to start with subutex treatment
- Primary Outcome Measures
Name Time Method ASI quationarry, neurocognitive computerized tests, MMSE test, Sexual function questionnaire and satisfaction questionnaire In 2 visits during the study
- Secondary Outcome Measures
Name Time Method